Literature DB >> 12562682

HIV protease inhibitors: antiretroviral agents with anti-inflammatory, anti-angiogenic and anti-tumour activity.

Paolo Monini1, Cecilia Sgadari, Giovanni Barillari, Barbara Ensoli.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12562682     DOI： 10.1093/jac/dkg086

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN： 0305-7453            Impact factor:   5.790


× No keyword cloud information.
  9 in total

Review 1.  Molecular Mechanisms of HIV Protease Inhibitors Against HPV-Associated Cervical Cancer: Restoration of TP53 Tumour Suppressor Activities.

Authors:  Lilian Makgoo; Salerwe Mosebi; Zukile Mbita
Journal:  Front Mol Biosci       Date:  2022-05-10

2.  Steady-state disposition of the nonpeptidic protease inhibitor tipranavir when coadministered with ritonavir.

Authors:  Linzhi Chen; John P Sabo; Elsy Philip; Yanping Mao; Stephen H Norris; Thomas R MacGregor; Jan M Wruck; Sandra Garfinkel; Mark Castles; Amy Brinkman; Hernan Valdez
Journal:  Antimicrob Agents Chemother       Date:  2007-05-07       Impact factor: 5.191

Review 3.  Tipranavir in the protease inhibitors arena.

Authors:  Barbara Vergani; Stefano Rusconi
Journal:  Drugs R D       Date:  2011-12-01

Review 4.  Abnormalities in alternative splicing of angiogenesis-related genes and their role in HIV-related cancers.

Authors:  Nonkululeko N Mthembu; Zukile Mbita; Rodney Hull; Zodwa Dlamini
Journal:  HIV AIDS (Auckl)       Date:  2017-03-30

Review 5.  Potential of small-molecule fungal metabolites in antiviral chemotherapy.

Authors:  Biswajit G Roy
Journal:  Antivir Chem Chemother       Date:  2017-07-23

6.  Causality, mediation and time: a dynamic viewpoint.

Authors:  Odd O Aalen; Kjetil Røysland; Jon Michael Gran; Bruno Ledergerber
Journal:  J R Stat Soc Ser A Stat Soc       Date:  2012-10       Impact factor: 2.483

7.  Insights into pathogenic events of HIV-associated Kaposi sarcoma and immune reconstitution syndrome related Kaposi sarcoma.

Authors:  Liviu Feller; Johan Lemmer
Journal:  Infect Agent Cancer       Date:  2008-01-21       Impact factor: 2.965

Review 8.  Marketed nonsteroidal anti-inflammatory agents, antihypertensives, and human immunodeficiency virus protease inhibitors: as-yet-unused weapons of the oncologists' arsenal.

Authors:  Panagiota Papanagnou; Panagiotis Baltopoulos; Maria Tsironi
Journal:  Ther Clin Risk Manag       Date:  2015-05-18       Impact factor: 2.423

9.  Oxidative Stress Mediates the Antiproliferative Effects of Nelfinavir in Breast Cancer Cells.

Authors:  Maria Soprano; Daniela Sorriento; Maria Rosaria Rusciano; Angela Serena Maione; Gennaro Limite; Pietro Forestieri; Dario D'Angelo; Matteo D'Alessio; Pietro Campiglia; Pietro Formisano; Guido Iaccarino; Roberto Bianco; Maddalena Illario
Journal:  PLoS One       Date:  2016-06-09       Impact factor: 3.240
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.